Solventum Corp | SOLV - Operating Expenses


Solventum Corp reported $4.99B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Align Technology USD 822.85M 11.8M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Cencora USD 82.77B 3.09B Sep/2025
Dexcom USD 936.6M 30.2M Dec/2025
Insulet USD 637.5M 48.9M Dec/2025
Solventum Corp USD 4.99B 3.04B Sep/2025
West Pharmaceutical Services USD 642.5M 2.41B Dec/2025
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025